Treatment of Bacterial Conjunctivitis
For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, choosing the most convenient or least expensive option since no evidence shows superiority of any particular agent. 1, 2
Initial Treatment Approach
Mild Bacterial Conjunctivitis
- Prescribe any broad-spectrum topical antibiotic for 5-7 days, 4 times daily 1, 2
- Acceptable first-line options include:
- Reserve fluoroquinolones (moxifloxacin, ofloxacin, ciprofloxacin) for moderate-to-severe cases with copious purulent discharge, pain, and marked inflammation, or for contact lens wearers at higher risk for Pseudomonas infection 1, 5
- Alternative when antibiotic access is limited: povidone-iodine 1.25% ophthalmic solution may be equally effective 1, 2
The rationale for this approach is that topical antibiotics accelerate clinical and microbiological remission by days 2-5, reduce transmissibility, and allow earlier return to school/work, even though mild bacterial conjunctivitis is self-limited 1, 2, 3. The American Academy of Ophthalmology explicitly states no clinical evidence suggests superiority of any particular antibiotic for mild cases 1.
Moderate-to-Severe Bacterial Conjunctivitis
- Obtain conjunctival cultures and Gram staining before starting treatment 1, 6, 2
- Start empiric fluoroquinolone therapy (moxifloxacin 3 times daily for 7 days) 5
- Adjust antibiotics based on culture results 2
- For MRSA infections, vancomycin may be required 1, 2
Special Situations Requiring Systemic Therapy
Gonococcal Conjunctivitis
- Requires systemic antibiotic therapy, not topical treatment alone 1, 6, 2
- Add saline lavage for comfort and faster resolution 1
- Daily follow-up until resolution 2
- If corneal involvement present, treat as bacterial keratitis 2
- Hospitalization may be necessary for severe cases and is mandatory for neonates 1
Chlamydial Conjunctivitis
- Requires systemic antibiotic therapy 1, 6, 2
- For neonates: erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days (clinical cure rate 96%, microbiological cure 97%) 1
- No evidence supports adding topical therapy beyond systemic treatment 1
- Follow-up evaluation is critical as treatment failure occurs in up to 19% of cases 2
- In children, consider sexual abuse as a possible cause 1, 2
Follow-Up and Red Flags
When to Reassess
- Instruct patients to return if no improvement after 3-4 days of treatment 1, 6, 2
- At follow-up: perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 1, 6
When to Refer to Ophthalmology
- Visual loss
- Moderate or severe pain
- Severe purulent discharge
- Corneal involvement
- Conjunctival scarring
- Lack of response to therapy
- Recurrent episodes
- Neonatal conjunctivitis (especially HSV, which can be life-threatening) 6
Critical Pitfalls to Avoid
- Do not prescribe antibiotics for viral conjunctivitis - this accounts for unnecessary costs and promotes resistance 1
- Avoid topical corticosteroids unless under close ophthalmologic supervision - they may prolong bacterial shedding and worsen infection 6
- Do not use topical therapy alone for gonococcal or chlamydial conjunctivitis - systemic treatment is mandatory 1, 6, 2
- Advise patients not to wear contact lenses during active infection 6, 5, 4
- Counsel on hygiene measures: frequent handwashing and avoiding sharing personal items 6
- Be aware of increasing bacterial resistance, particularly MRSA 1, 6, 2